Introduction
============

Cervical carcinogenesis is a consequence of persistent infection with high-risk human papillomaviruses (hr-HPV) [@B1]. In recent years, convincing data have emerged that a tumor-associated immune microenvironment must be an important determinant of susceptibility to HPV-related cervical cancer [@B2]. Invasion and metastasis are the primary causes of treatment failure and subsequent death in cervical cancer patients. Moreover, metastasis to lymphatic vessels indicates an unfavorable prognosis [@B3], [@B4]. Malignant tumors are complex structures that must interact with the surrounding environment for growth and invasiveness. However, the molecular alterations in the tumor-associated immune microenvironment that drive invasion and metastasis in cervical cancer are not well established. These observations underscore the urgent need to identify new biomarkers with the potential to predict tumor progression, enable diagnosis at earlier stages of the disease, and facilitate the rapid detection of disease recurrence or metastasis following treatment.

Macrophages are critical immune effector cells and one of the major components of tumor-infiltrating leukocytes. These cells play a key role, in terms of their increased levels and their function, in the processes associated with carcinogenesis [@B5]. Macrophages are derived from blood monocytes and can polarize into M1 (classically activated) or M2 (alternatively activated) subpopulations within the tumor microenvironment (TME) [@B6], [@B7]. Accordingly, macrophages that infiltrate and surround the tumor nest are defined as tumor-associated macrophages (TAMs) [@B8]. TAMs can interact with neoplastic cells by releasing various cytokines that can contribute to cancer initiation and progression. Emerging data suggest that high numbers of TAMs in various types of carcinomas are associated with a poor prognosis [@B9]-[@B11].

Tumor-associated viruses lead to malignancies with a prolonged latency and in conjunction with TME. One of the hallmarks of oncogenic virus-related inflammation is the recruitment of monocyte-macrophage lineage cells to the TME. Several reports suggest that viral infection promotes macrophage activation and M2 polarization [@B12], [@B13]. In recent years, strong evidence has emerged that TAMs play a critical role in the induction of virus-associated malignant tumors [@B14]-[@B16]; this highlights the necessity to further explore the influence of TAMs on HPV-related cervical carcinogenesis.

There are several known functional markers of TAMs, and the presence of CD163 versus CD68 is a key distinguishing factor between different TAMs. CD163, a member of the scavenger receptor cysteine-rich family, is involved in anti-inflammatory functions and is predominantly expressed on M2 macrophages [@B17]. Accumulating evidence indicates that a high number of TAMs, as demonstrated by exclusive immunohistochemistry (IHC) staining with antibodies against CD163, is associated with an unfavorable prognosis in a variety of malignancies [@B18]-[@B20]. However, CD68, the well-established generic macrophage marker, could not distinguish M1 or M2 subtypes from all the infiltrated macrophages [@B21]. On the basis of these reports, we hypothesized that CD163+ macrophages might be a subpopulation of CD68+ macrophages and are more suitable to identify the tumor-promoting macrophages.

In this study, the distribution and clinical significance of macrophages in cervical squamous dysplasia and carcinoma were evaluated with the markers of CD163 and CD68, and the association between CD163+ macrophages/CD68+ macrophages and hr-HPV infection was analyzed. We also studied the differences between these two markers.

Materials and methods
=====================

Tissue samples
--------------

Between January 2011 and December 2013, 130 archival formalin-fixed paraffin-embedded cervical specimens were obtained from the Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University. The specimens included 26 cases of normal cervical tissues, 30 cases of cervical intraepithelial neoplasia (CIN) I, 29 cases of CIN II-III, and 45 cases of squamous cell carcinoma (SCC) (range from stage I to II). Specimens of lesions were selected consecutively from cervical biopsies (8 cases), loop electrosurgical excision procedure specimens (22 cases), cone biopsies (29 cases), and radical hysterectomy and pelvic lymphadenectomy (45 cases). Twenty-six cases of normal cervical tissues were obtained from patients undergoing hysterectomy for benign conditions without a history of CIN or abnormal Pap smears. All the 45 cases of cervical cancer were submitted for pathological examination after operation. Pregnant women and patients with acute pelvic infection were excluded from the study. Patients in whom adenocarcinoma was diagnosed were excluded. Patients who had received cervical therapy or preoperative treatment, such as radiotherapy and chemotherapy, were also excluded. As outlined in Table [1](#T1){ref-type="table"}, HPV test was performed using the hybrid capture II (HC-II, Digene). The cervical specimens were divided into four histological groups: normal, CIN I, CIN II-III, SCC. Clinical pathologic characteristics of the tumor (e.g. age, FIGO stage, histology, lymph node status) were provided by the Department of Obstetrics and Gynecology and Department of Pathology, Nanfang Hospital, Southern Medical University. Informed consent was obtained from each patient before using the samples. Serial sections were prepared for hematoxylin and eosin staining and IHC analysis. Two experienced pathologists who had no prior knowledge of the patient data reviewed the slides for all cases to confirm the previous diagnosis independently.

Immunohistochemistry
--------------------

IHC was performed as previously described [@B22], [@B23]. Briefly, 4-μm-thick consecutive paraffin sections were deparaffinized and rehydrated. Endogenous peroxidase activity was blocked by incubating for 30 min in 3% H~2~O~2~ in methanol at room temperature. Antigen retrieval was performed using a microwave treatment for 15 min in citrate buffer (pH 6.0). The sections were then blocked with 10% goat serum at 37°C for 1 h and incubated with mouse monoclonal anti-human primary antibodies against CD163 or CD68 (both applied at 1:200, Abcam, USA) in a humidified chamber overnight at 4°C. Next, the sections were incubated with secondary antibody and processed with the universal SP histostain™-plus kit (ZYMED, USA). Finally, the slides were counterstained with hematoxylin.

Evaluation of Immunohistochemistry
----------------------------------

Macrophage infiltration was quantitatively estimated in three separate compartments: the epithelium, the stroma, and both compartments combined. Each specimen was screened at low magnification (×100), and the five areas with greatest number of positively stained cells (hot spot area) were selected for further analysis. The mean macrophage count in these five areas for each case was estimated (per mm^2^) at high power (×400) magnification. The percentage of immunoreactivity was scored from 0 to 3 according to the proportion of positively stained cells as follows: 0, \<5%; 1, 5%-20%; 2, 20%-50%; 3, \>50%. A score of 2 to 3 was classified as high-level expression and 0 to 1 as low-level expression. Mean macrophage count was determined by two independent pathologists who were blinded to the patient\'s pathological and clinical status. To confirm the reproducibility, 25% of the slides were chosen randomly and scored twice. All duplicates were evaluated in a similar manner.

Statistical Methods
-------------------

Statistical data were analyzed was performed using the IBM Statistical Package for Social Sciences for Windows (version 20.0, IBM, Armonk, NY, USA). T test and one-way ANOVA were used to determine the statistical significance of the differences between the two macrophage populations (CD163+ and CD68+). Frequency tables were analyzed using the Fisher Exact Test, with Spearman and Pearson Correlation Coefficient used to assess the significance of correlations between categorical variables. Values with distribution are presented as mean ± standard deviation. All tests were two-tailed, and *p* \< 0.05 was considered statistically significant.

Results
=======

Upregulation of CD68+ macrophages is correlated with cervical malignant transformation
--------------------------------------------------------------------------------------

CD68 was localized within the cytoplasm of the macrophages and exhibited granular, brownish staining in cervical specimens (Figure [1](#F1){ref-type="fig"}A). The progression from the normal cervical epithelium to dysplasia and SCC was associated with a progressive increase in the immunoreactivity of CD68+ macrophages (100× magnification) (Figure [1](#F1){ref-type="fig"}C).

The expression levels of CD68+ macrophages in the four histological groups, i.e, normal cervical tissue, CINI, CINII-III, and SCC, were analyzed. Statistical analysis revealed that the levels of total CD68+ macrophages in SCC tissues were significantly higher than those in the normal cervical tissue (*p* \< 0.05), CINI (*p* \< 0.05), and CIN II-III (*p* \< 0.05). In addition, an upregulation of CD68+ macrophages was observed in CIN II-III compared with that in CIN I (*p* \< 0.05) and normal tissues (*p* \< 0.05). The number of total CD68+ macrophages in tissues of increasing histological grade, from normal cervix to SCC, was 12.5, 46.2, 93.5, and 178.7 (Figure [2](#F2){ref-type="fig"}A), respectively. A positive association between CD68+ macrophage expression and cervical carcinogenesis and carcinoma progression was observed when we analyzed the immunoreactivity of CD68 (Spearman\'s rho = 0.478, *p* = 0.000) (Figure [2](#F2){ref-type="fig"}B).

Upregulation of CD163+ macrophages is correlated with cervical malignant transformation
---------------------------------------------------------------------------------------

CD163 immunoreactivity is characterized by a granular brownish pattern and membrane staining in cervical specimens (Figure [1](#F1){ref-type="fig"}B). CD163 staining pattern exhibited a cleaner background than CD68 with less nonspecific staining of carcinoma cells and other inflammatory elements (Figure [1](#F1){ref-type="fig"}A-[1](#F1){ref-type="fig"}B). The more advanced the lesions of the cervix, the higher was the immunoreactivity of CD163+ macrophages (100× magnification) (Figure [1](#F1){ref-type="fig"}C).

We also observed a progressive increase in total CD163+ macrophages with increasing histological grade (from normal tissue to SCC), with cell counts ranging from a median value of 8.3 in normal tissues to 145.7 in SCC (Figure [2](#F2){ref-type="fig"}C). The expression level of CD163 was significantly higher in SCC than in different CINs (all *p* \< 0.05), and the CD163 expression levels in different CINs were also higher than that in normal cervix (all *p* \< 0.05). In addition, the difference was statistically significant between the early and late stages of CIN (*p* \< 0.05). The density of CD163+ macrophages demonstrated a positive correlation with the progression of cervical carcinogenesis (Spearman\'s rho = 0.676, *p* = 0.000) (Figure [2](#F2){ref-type="fig"}D).

Expression of both CD68+ and CD163+ macrophages is related to hr-HPV infection
------------------------------------------------------------------------------

The relationship between the expression of either CD68+ or CD163+ macrophages and hr-HPV infection in cervical lesions was assessed. Results of hr-HPV infection rates were available for 26 normal, 30 CIN I, 29 CIN II-III, and 45 SCC cases at 11.5%, 70%, 93.1%, and 100%, respectively.

The density of both CD163+ and CD68+ macrophage counts was significantly greater in the hr-HPV-positive group than in the hr-HPV-negative group (all *p* \< 0.05) (Figure [3](#F3){ref-type="fig"}A). As shown in Table [1](#T1){ref-type="table"}, there was a significant correlation between the different grades of CD163+ and the hr-HPV infection status in different histological cervical lesions: normal, CIN I, CIN II-III, SCC (all *p*\<0.05). The expression of CD68+ macrophages was significantly correlated with hr-HPV infection in cervical lesions of CIN II-III and SCC (both *p*\<0.05). In all the cases, high expression levels of CD163+ and CD68+ macrophages were more frequent in hr-HPV-positive lesions than those in hr-HPV-negative lesions, of which 55.9% had low expression for CD68 (19 of 34) and 73.5% for CD163 (25 of 34). In the hr-HPV-positive cases, 80.2% (77 of 96) showed high expression of CD68, as compared to 44.1% (15 of 34) of the hr-HPV-negative cases. High levels of CD163+ macrophage expression in all cases infected with hr-HPV was significantly higher (11.6% for normal, 56.7% for CIN I, 79.3% for CIN II-III, 88.9% for SCC) than those without hr-HPV infection (23% for normal, 10% for CIN I, 0% for CIN II-III, 0% for SCC).

CD163+ macrophages tend to correlate with malignant transformation of the cervix more obviously than CD68+ macrophages
----------------------------------------------------------------------------------------------------------------------

Although the average number of CD68+ macrophages was higher than that of CD163+ macrophages, the total macrophage counts revealed that the number of CD68+ macrophages was directly correlated with the number of CD163+ macrophages (Pearson Correlation = 0.808, *p* = 0.000) (Figure [3](#F3){ref-type="fig"}B). We also studied CD163+ macrophage/CD68+ macrophage infiltration in either stroma or epithelium of the four histological groups respectively (Figure [3](#F3){ref-type="fig"}C). The stromal compartment consistently demonstrated higher counts than the epithelium for both CD163+ and CD68+ macrophages. The stroma/epithelium ratio of CD163+ and CD68+ macrophages significantly decreased as the lesions progressed, indicating a macrophage switch from the stroma to the epithelium, which was more obvious for CD163+ macrophages.

CD163+ macrophages tend to correlate with FIGO stage and lymph node metastasis of cervical cancer more closely than CD68+ macrophages
-------------------------------------------------------------------------------------------------------------------------------------

To investigate the clinical significance of CD163+ and CD68+ macrophages levels in cervical carcinoma, we evaluated the correlation between the levels of CD163+ macrophages/CD68+ macrophages and the clinicopathological features in serial sections of the same tissues. As shown in Table [2](#T2){ref-type="table"}, CD163+ and CD68+ macrophages were not significantly correlated with age or histologic type (all *p* \> 0.05). The counts of total CD163+ macrophages were significantly increased in cases presenting with lymph node metastasis and higher FIGO stages (*p* = 0.012,*p* = 0.009, respectively); however, the same results were not observed for CD68+ macrophages (*p* = 0.079,*p* = 0.067, respectively).

Previous studies have suggested that late FIGO stages and lymph node metastasis are the primary causes of treatment failure and subsequent death in patients with cervical cancer [@B3], [@B4]. Thus, we further explored the correlation between macrophage expression and FIGO stage/lymph node metastasis. As shown in Table [3](#T3){ref-type="table"}, increasing CD163+ macrophage counts correlated with a more advanced tumor stage (Spearman\'s rho = 0.502, *p* = 0.020). However, there was no significant difference between CD68+ macrophage expression and FIGO stage (Spearman\'s rho = 0.389, *p* = 0.137). In addition, CD163+ macrophage expression was more significantly correlated with lymph node metastasis than CD68+ macrophage expression (Spearman\'s rho = 0.637, *p* = 0.005; Spearman\'s rho = 0.407, *p* = 0.085, respectively).

Discussion
==========

HPV-related cervical carcinogenesis is a complex structure that relies on interactions with the surrounding environment to promote their growth and invasive capabilities. Chronic inflammation of virus-associated malignant tumors is characterized by the infiltration of various leukocyte populations including activated macrophages [@B24]. Accumulating evidence suggests that a high number of TAMs in TME is strongly associated with viral infection [@B14]-[@B16]. Our findings suggest a critical role for both CD163+ and CD68+ macrophages in HPV infection and demonstrate a strong association between the malignant transformation of the cervix and an increase in the number of CD163+ and CD68+ macrophages. These data support a role of TAMs as a prospective predictor for HPV-related cervical carcinogenesis, which highlight the importance for a further study of TAMs involved in cervical cancer.

We further investigated the specific distribution of both CD163+ and CD68+ macrophages in cervical cancer tissue. In most of the samples that we evaluated, both CD163+ and CD68+ macrophages localized in the same tissue regions. However, CD163 showed lower staining levels than CD68, with less nonspecific staining of background inflammatory cells or carcinoma cells. CD68 immunostaining can be observed in multiple cell types, such as fibroblasts and inflammatory cells. In the case of cervical carcinoma, there are myriad of inflammatory and stromal elements surrounding the relatively few neoplastic cells, and high background staining can complicate the results when using the nonspecific CD68 marker. CD163 appears to be a more accurate marker for identifying TAMs in cervical carcinoma.

Currently, accumulating evidence indicates that the interaction of the tumor stroma, a key component of the TME, with cancer cells might facilitate the process of tumor progression [@B25]. In our study, the stromal compartment consistently demonstrated higher macrophage counts than the epithelium. We also found that increased macrophage counts in the epithelium were directly correlated with malignant transformation in cervical cancer and that this correlation was particularly pronounced for CD163+ macrophages. Therefore, we presume that tumor cells in the TME secrete various types of cytokines to promote the migration of monocytes to the tumor tissue and that macrophages infiltrating the nests can directly interact with the tumor cells. Moreover, this finding highlights the crucial role of CD163+ macrophages. As opposed to CD68+ macrophage infiltration, a high level of CD163+ macrophage infiltration was more strongly associated with malignant transformation in cervical cancer.

Interestingly, regarding the patient clinicopathological data, a high CD163+ macrophage count was significantly associated with advanced FIGO stage and lymph node metastasis. A potential mechanism to explain the clinical relevance of these findings is that, upon activation by tumors, macrophages adopt a phenotype associated with poor antigen-presenting capability, suppression of T cell proliferation, increased angiogenesis, and increasing tissue remodeling capability. Together, these effects facilitate tumor cell invasion and metastasis [@B26]. Because advanced disease stage and lymph node metastasis is the major cause for cervical cancer-related deaths, we considered that CD163+ macrophages have a clinical significance as a prognostic indicator in patients with cervical cancer. An association between the number of CD68+ macrophages and lymph node metastases was identified by Ding and Dongju *et al*. [@B27], [@B28]. Other groups, in accordance with our observation, have not been able to reproduce these results [@B29]. Our study (in which lesions IHC data were compared with clinicopathological data) reported a positive association between infiltrating CD163+ macrophages and cervical carcinogenesis and carcinoma progression; this finding will be valuable to further research investigating the significance of TAMs in cervical cancer.

There is an increasing body of evidence suggesting that increased TAMs infiltration in human tumors is associated with a poor prognosis [@B9]-[@B11], [@B18]-[@B20]. Interestingly, some researchers argued that the level of CD163+ macrophages is a better prognostic indicator than CD68 [@B30]-[@B32]. However, there are few reports on the role of CD163+ and CD68+ macrophages in cervical carcinoma, and data regarding their prognostic relevance are limited and disputable. Carus *et al.* studied 101 FIGO stage IB and IIA cervical cancer patients and found that the peritumoral CD163+ macrophage count was significantly associated with reduced recurrence-free survival (RFS) [@B33]. In HPV-related cervical cancer, the intraepithelial infiltration with high numbers of M1 macrophages is an independent prognostic factor for a favorable survival [@B34]. Nedergaard *et al.* reported that no significant association between CD68+ macrophages and tumor recurrence [@B35]. The current study demonstrates that the capability of macrophage counts, as assessed by IHC, to predict the prognosis of cervical cancer patients needs to be further explored.

In conclusion, our study clearly demonstrates a positive association between the expression of either CD68+ or CD163+ macrophages and cervical carcinogenesis. The number of macrophage increase linearly with the infection of hr-HPV. The level of CD163+ macrophages exhibited a stronger correlation with the advanced FIGO stage and lymph node metastasis of cervical cancer than CD68+ macrophages. Additionally, CD163 exhibited cleaner background immunostaining than CD68. These results suggest that TAMs might offer a novel approach for cervical cancer treatment, and in upcoming trials, CD163+ macrophages should be investigated as a potential marker of disease progression. However, because of our limited sample size, we were unable to evaluate the prognostic capability of CD163+ and CD68+ macrophages in cervical cancer. Additional studies with larger sample sizes and prospective cases are required to verify the significance of macrophage infiltration as a prognostic marker in cervical carcinoma. Furthermore, our study should promote further exploration on the mechanism by which HPV and TAMs cooperate in the tumor microenvironment and how this cooperation influences cervical carcinogenesis and metastasis.
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![**Immunohistochemical detection of CD68+ and CD163+ macrophage expression in different cervical tissues.** Representative immunostaining of CD68 (A) and CD163 (B) on consecutive sections of paired cervical tissue (magnification×100 left and × 400 right). (C) Normal cervical tissue showed weak positive staining with scattered CD68+ and CD163+ macrophages. Cervical intraepithelial neoplasia (CIN) I displayed weak positive staining with few CD68+ and CD163+ macrophages. CIN II-III showed strong immunohistochemical staining with the increase in CD68+ and CD163+ macrophage population. Squamous cell carcinoma (SCC) showed intense staining and high count of CD68+ and CD163+ macrophages.](jcav08p3868g001){#F1}

![**Upregulation of both CD68+ and CD163+ macrophages is correlated with cervical carcinogenesis and carcinoma progression.** The infiltration density of CD68+ (A) and CD163+ macrophages (C) in normal cervical tissue, cervical intraepithelial neoplasia (CIN) I, CIN II-III, and squamous cell carcinoma (SCC). Bars indicate median immunostaining score values. The level of CD68+ (B) and CD163+ (D) macrophage expression showed a positive correlation with cervical malignant transformation (r = 0.487, p = 0.000; r = 0.676, p = 0.000; Spearman correlation coefficient test). The line represents the calculated regression line.](jcav08p3868g002){#F2}

![**The correlation between CD68+ and CD163+ macrophages during cervical carcinogenesis and carcinoma progression.** (A) Significant differences in the mean macrophage counts between the subgroups with or without high-risk human papillomavirus (hr-HPV) infection (all *p* \< 0.05). (B) Correlation of macrophages measured by CD68 or CD163 in different histological cervical lesions. The level of CD68+ macrophages showed a positive correlation with CD163+ macrophages (r = 0.808, *p* = 0.000, Pearson Correlation Coefficient). The line represents the calculated regression line. (C) The counts of CD68+ and CD163+ macrophages (per ×400 field) in epithelium (white bars) and stroma (black bars) in different histological cervical lesions: normal, cervical intraepithelial neoplasia (CIN) I, CIN II-III, squamous cell carcinoma (SCC). Values presented in median (25th-75th percentile).](jcav08p3868g003){#F3}

###### 

Correlation of CD68 and CD163 expression with hr-HPV infection

  Group        hr-HPV     CD68                 CD163   Total                
  ------------ ---------- ---------- --------- ------- ---------- --------- ----
  Normal       P          2(7.7)     1(3.8)            3(11.6)    0(0)      3
  N            10(38.5)   13(50)               6(23)   17(65.4)   23        
  CIN I        P          15(50)     6(20)             17(56.7)   4(13.3)   21
  N            5(16.7)    4(13.3)              3(10)   6(20)      9         
  CIN II-III   P          23(79.3)   4(13.8)           23(79.3)   4(13.8)   27
  N            0(0)       2(6.9)               0(0)    2(6.9)     2         
  SCC          P          37(82.2)   8(17.8)           40(88.9)   5(11.1)   45
  N            0(0)       0(0)                 0(0)    0(0)       0         
  Total                   92         38                92         38        

\*Data are given as number (percentage). Fisher Exact Test, *P*\<0.05.

CIN = cervical intraepithelial neoplasia; SCC = squamous cell carcinoma; hr-HPV = high-risk human papillomavirus; H = high expression; L = low expression; N = negative; P = positive

###### 

Correlation of increased CD68 and CD163 expression with clinicopathologic features

  ----------------------------------------------------------------------------------------------------------------
                           Density of total CD163+\             Density of total CD68+\                         
                           macrophage cell number               macrophage cell number                          
  ------------------- ---- -------------------------- --------- ------------------------- ------------- ------- --
  **Age**                                                                                                       

  \<45 years          19   120.75±40.8                0.263                               137.57±41.3   0.310   

  ≥45 years           26   117.59±46.6                                                    132.92±45.9           

  **FIGO stage**                                                                                                

  I                   21   104.60±34.8                0.009\*                             130.26±34.3   0.067   

  II                  24   133.71±40.3                                                    140.21±42.8           

  **Histology**                                                                                                 

  High                13   123.74±42.1                0.573                               138.70±31.9   0.650   

  Middle              20   115.60±46.3                                                    129.89±41.4           

  Low                 12   118.40±32.6                                                    136.90±42.8           

  **LN metastasis**                                                                                             

  Negative            18   100.02±31.2                0.012\*                             126.41±37.6   0.079   

  Positive            27   138.40±45.5                                                    144.13±45.8           
  ----------------------------------------------------------------------------------------------------------------

\*Statistical significance *(P*\<0.05) was calculated using the t test and one-way ANOVA.

FIGO = International Federation of Gynecology and Obstetrics; LN = lymph node.

###### 

Spearman correlation coefficient of increased CD68 and CD163 expression with clinicopathologic features

  Variable        CD163+ macrophages             CD68+ macrophages           
  --------------- -------------------- --------- ------------------- ------- -------
  FIGO stage      0.502                0.020\*                       0.389   0.137
  LN metastasis   0.637                0.005\*                       0.407   0.085

\*Statistical significance *(P*\<0.05) was calculated using the Spearman correlation coefficient.

FIGO = International Federation of Gynecology and Obstetrics; LN = Lymph node.
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